First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months
18 October 2011 | By GlaxoSmithKline
RTS,S* reduces the risk of malaria by half...
List view / Grid view
18 October 2011 | By GlaxoSmithKline
RTS,S* reduces the risk of malaria by half...
25 April 2013 | By Novartis
"We believe that this innovative campaign will help speed malaria elimination..."
28 November 2013 | By Novartis
Novartis scientists have discovered a new drug target for treating malaria...
9 November 2012 | By GlaxoSmithKline
Results from ongoing Phase III clinical trial announced...
5 May 2011 | By Sanofi-Aventis
Sanofi-aventis and MMV announced that they have signed an alliance agreement...
12 November 2014 | By Novartis
Novartis announced that, through Power of One, enough funds have been raised to deliver three million antimalarial treatments for children in Zambia...
2 December 2020 | By Hannah Balfour (European Pharmaceutical Review)
The WHO’s World malaria report suggests the progress in eradicating malaria has slowed due to funding shortages and that COVID-19 disruptions could result in additional deaths.
28 June 2010 | By AstraZeneca
AstraZeneca and Medicines for Malaria Venture (MMV) today announced a collaborative agreement designed to identify novel candidate drugs for the treatment of malaria...
8 July 2015 | By Victoria White
Sanofi is to extend its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new single, fixed-dose combination therapy for malaria...
8 October 2013 | By GlaxoSmithKline
These latest results demonstrated that over 18 months of follow-up, RTS,S was shown to almost halve the number of malaria cases...
12 August 2021 | By Anna Begley (European Pharmaceutical Review)
One dose of a monoclonal antibody developed at the US National Institutes of Health (NIH) prevented malaria for up to nine months.
29 November 2011 | By Sanofi
Sanofi organizes the 10th Edition of the Pan-African Conference against Malaria with representatives of 34 African Countries...
22 August 2022 | By Hannah Balfour (European Pharmaceutical Review)
Securing 18 million doses of GSK’s RTS,S malaria vaccine, UNICEF calls the contract a major breakthrough for child health.
20 February 2017 | By Niamh Marriott, Digital Editor
Umeå University researches have established links between patterns of malaria in Kenya and environmental factors measurable by satellite imagery...
7 October 2021 | By Anna Begley (European Pharmaceutical Review)
The World Health Organization (WHO) recommends GSK's RTS,S/AS01 (RTS,S) malaria vaccine for use in children in sub-Saharan Africa.